Shuttle Pharmaceuticals (SHPH) Competitors $3.92 +0.12 (+3.16%) Closing price 04:00 PM EasternExtended Trading$3.80 -0.12 (-3.04%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SHPH vs. THAR, ASBP, TRAW, LPCN, IBIO, NRSN, LGVN, PULM, MTEX, and NAIIShould you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include Tharimmune (THAR), Aspire Biopharma (ASBP), Traws Pharma (TRAW), Lipocine (LPCN), iBio (IBIO), NeuroSense Therapeutics (NRSN), Longeveron (LGVN), Pulmatrix (PULM), Mannatech (MTEX), and Natural Alternatives International (NAII). These companies are all part of the "pharmaceutical products" industry. Shuttle Pharmaceuticals vs. Its Competitors Tharimmune Aspire Biopharma Traws Pharma Lipocine iBio NeuroSense Therapeutics Longeveron Pulmatrix Mannatech Natural Alternatives International Shuttle Pharmaceuticals (NASDAQ:SHPH) and Tharimmune (NASDAQ:THAR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk. Which has preferable valuation and earnings, SHPH or THAR? Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than Tharimmune, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShuttle PharmaceuticalsN/AN/A-$9.15M-$4.15-0.94TharimmuneN/AN/A-$12.20M-$6.10-0.51 Do institutionals & insiders believe in SHPH or THAR? 4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. Comparatively, 1.2% of Tharimmune shares are owned by institutional investors. 12.6% of Shuttle Pharmaceuticals shares are owned by insiders. Comparatively, 25.6% of Tharimmune shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, SHPH or THAR? Shuttle Pharmaceuticals has a beta of -1.01, suggesting that its stock price is 201% less volatile than the S&P 500. Comparatively, Tharimmune has a beta of 1.41, suggesting that its stock price is 41% more volatile than the S&P 500. Does the media prefer SHPH or THAR? In the previous week, Shuttle Pharmaceuticals had 6 more articles in the media than Tharimmune. MarketBeat recorded 11 mentions for Shuttle Pharmaceuticals and 5 mentions for Tharimmune. Tharimmune's average media sentiment score of 0.52 beat Shuttle Pharmaceuticals' score of 0.17 indicating that Tharimmune is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shuttle Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tharimmune 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is SHPH or THAR more profitable? Shuttle Pharmaceuticals' return on equity of -772.76% beat Tharimmune's return on equity.Company Net Margins Return on Equity Return on Assets Shuttle PharmaceuticalsN/A -772.76% -347.06% Tharimmune N/A -1,239.20%-365.06% Do analysts prefer SHPH or THAR? Tharimmune has a consensus price target of $17.00, indicating a potential upside of 444.87%. Given Tharimmune's stronger consensus rating and higher probable upside, analysts clearly believe Tharimmune is more favorable than Shuttle Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Tharimmune 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67 SummaryTharimmune beats Shuttle Pharmaceuticals on 8 of the 14 factors compared between the two stocks. Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHPH vs. The Competition Export to ExcelMetricShuttle PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.07M$2.64B$6.06B$10.53BDividend YieldN/A57.77%5.73%4.79%P/E Ratio-0.9422.5685.0527.24Price / SalesN/A754.19593.90135.46Price / CashN/A174.0137.5761.53Price / Book0.905.3612.676.74Net Income-$9.15M$33.06M$3.32B$276.59M7 Day Performance-6.67%0.71%0.50%0.86%1 Month Performance9.19%10.16%9.42%8.17%1 Year Performance-87.17%-0.86%79.11%43.66% Shuttle Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHPHShuttle Pharmaceuticals0.7187 of 5 stars$3.92+3.2%N/A-86.4%$4.07MN/A-0.945Analyst ForecastTHARTharimmune2.4626 of 5 stars$3.02-0.3%$17.00+462.9%+46.9%$17.83MN/A-0.502Gap DownASBPAspire BiopharmaN/A$0.36-6.7%N/AN/A$17.79MN/A0.00N/AGap DownTRAWTraws Pharma0.8143 of 5 stars$2.50+11.6%N/A-44.4%$17.66M$2.90M0.0317News CoverageLPCNLipocine3.1481 of 5 stars$3.22+0.6%$8.00+148.4%-39.5%$17.45M$11.20M-3.7010High Trading VolumeIBIOiBio1.8783 of 5 stars$0.87+2.3%$5.00+475.2%-69.3%$17.09M$400K-0.50100NRSNNeuroSense Therapeutics2.2657 of 5 stars$1.15-1.7%$14.00+1,117.4%+8.0%$17.08MN/A-2.1310LGVNLongeveron2.5947 of 5 stars$0.81+2.3%$7.67+847.7%-55.3%$17.04M$2.39M-0.1320PULMPulmatrix0.9653 of 5 stars$4.65-8.1%N/A+130.8%$16.97M$369K-2.1420Positive NewsMTEXMannatech0.9138 of 5 stars$8.89-1.2%N/A+30.6%$16.90M$112.98M-4.36250News CoverageGap DownNAIINatural Alternatives International1.5761 of 5 stars$2.71-1.8%N/A-42.5%$16.75M$129.86M-1.19290Gap UpHigh Trading Volume Related Companies and Tools Related Companies THAR Alternatives ASBP Alternatives TRAW Alternatives LPCN Alternatives IBIO Alternatives NRSN Alternatives LGVN Alternatives PULM Alternatives MTEX Alternatives NAII Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHPH) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersWhy Wall Street is piling into the “Debasement Trade”Wall Street is piling into what insiders are calling the “Debasement Trade” — and according to former Goldman ...Stansberry Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you want a way to generate consistent market income without chasing volatile AI stocks or complex crypto tr...Base Camp Trading | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
